Policy WatchMarch 20, 2026. 10 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.govSchedules...
Study: Consumers Show No Impairment in Their Next-Day Driving Performance Despite Residual THC Blood Levels
Your morning commute might be biochemically more complicated than you think, but the data suggests your insurance company can relax. Residual THC in your bloodstream apparently doesn't translate to the fumbling steering...
New Hampshire: Senate Republicans Kill House-Backed Adult-Use Marijuana Legalization Bill
When legislative priorities shift faster than cannabinoid metabolism, patients in need of legal access are left holding an empty prescription pad. Via r/trees Further Reading CED Clinic BlogCannabis-Based Medicines Show Promise for...
`Cannabinoid Clinical Trials: CBD and Cortical Excitability`
Clinical Takeaway In a controlled trial of healthy males, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability or sedation compared...
endocannabinoid system clinical research: Cannabis Sleep Trial EEG
Clinical Takeaway In this pilot RCT of 20 adults with diagnosed insomnia, a single oral dose of 10 mg THC combined with 200 mg CBD reduced total sleep time compared to placebo,...
Endocannabinoid System Research: Cannabis for Anxiety
Clinical Takeaway Cannabis use was associated with daily reductions in anxiety, but the effects differed meaningfully depending on whether participants used flower or edible products and the cannabinoid composition (CBD, THC, or...
Cannabidiol for Fibromyalgia: Evidence-Based Clinical Trial
Clinical Takeaway In this randomized, double-blind, placebo-controlled trial, CBD did not demonstrate superiority over placebo in reducing pain among patients with fibromyalgia. These findings highlight the gap between widespread patient use of...
`Endocannabinoid System Research: Cannabis for PTSD and SUD`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who also use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care solely because...
endocannabinoid system clinical research: Mobile Mental Health RCT
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-designed with university students, to address mental health and substance use concerns during a high-risk transitional period. The study evaluated whether...
Cannabinoid Clinical Trials in Athlete Mental Health Care
Clinical Takeaway Retired professional athletes from high contact team sports like football, rugby, and hockey face elevated rates of depression, anxiety, and cognitive concerns compared to the general population, with symptoms often...